Lck

Lck (lymphocyte-specific protein tyrosine kinase) is a Src-family non-receptor tyrosine kinase that functions as a central initiator of T-cell activation and antigen receptor signaling through phosphorylation-dependent intracellular signal transduction mechanisms^[1][2]. Mechanistically, Lck operates at the proximal stage of the T-cell receptor (TCR) signaling pathway, where it phosphorylates immunoreceptor tyrosine-based activation motifs (ITAMs) and promotes downstream signaling events required for T-cell activation, differentiation, and immune responses^[2][3]. Genetic studies demonstrated that loss of functional Lck disrupts TCR-mediated signaling and impairs cellular responsiveness, establishing its essential role in lymphocyte biology and experimental models of immune deficiency^[4]. Disease relevance is supported by evidence linking LCK deficiency to severe immunological dysfunction, while dysregulated Lck signaling has also been investigated in hematologic malignancies and other immune-associated disorders^[1][4]. Compared with related Src-family kinases, particularly Fyn, Lck has a more dominant role in initiating proximal TCR signaling, whereas Fyn contributes to overlapping but nonessential signaling functions in many T-cell activation contexts^[3][5]. Structurally, Lck contains SH2, SH3, and catalytic kinase domains that coordinate activation-state regulation through phosphorylation-dependent conformational changes^[2]. For experimental applications, Lck remains a widely used target for kinase inhibition studies and mechanistic analyses of T-cell signaling networks, making it a valuable tool for immune signaling research and therapeutic target validation^[6].